Its about realistic changes for long-lasting impact.
In contrast, SGLT2 inhibitor monotherapy is not likely to provide sufficient weight loss for treatment of obesity per se, but could have other benefits in obese patients with co-morbidities such as atherosclerotic cardiovascular disease, heart failure, or renal disease
Drug companies are cashing in while they can Novo Nordisk, the Danish creator of Ozempic and Wegovy, made $4.8 billion from the drugs in the third quarter of 2023 alone, boosting the economy in Denmark and leading to lower interest rates for ordinary Danes
The AS-related E6-AP was found in the nucleus, neuronal synapse, and presynaptic and postsynaptic compartments of the cultured hippocampal neurons [380]
Many users with prediabetes see glucose tolerance normalize
Understanding when these medications may be appropriate helps set realistic expectations and supports informed decision-making